Molecular characterization of L-CPT I deficiency in six patients: Insights into function of the native enzyme

N. F. Brown, R. S. Mullur, I. Subramanian, V. Esser, M. J. Bennett, J. M. Saudubray, A. S. Feigenbaum, J. A. Kobari, P. M. Macleod, J. D. McGarry, J. C. Cohen

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Carnitine palmitoyltransferase I (CPT I) catalyzes the formation of acylcarnitine, the first step in the oxidation of long-chain fatty acids in mitochondria. The enzyme exists as liver (L-CPT I) and muscle (M-CPT I) isoforms that are encoded by separate genes. Genetic deficiency of L-CPT I, which has been reported in 16 patients from 13 families, is characterized by episodes of hypoketotic hypoglycemia beginning in early childhood and is usually associated with fasting or illness. To date, only two mutations associated with L-CPT I deficiency have been reported. In the present study we have identified and characterized the mutations underlying L-CPT I deficiency in six patients: five with classic symptoms of L-CPT I deficiency and one with symptoms that have not previously been associated with this disorder (muscle cramps and pain). Transfection of the mutant L-CPT I cDNAs in COS cells resulted in L-CPT I mRNA levels that were comparable to those expressed from the wild-type construct. Western blotting revealed lower levels of each of the mutant proteins, indicating that the low enzyme activity associated with these mutations was due, at least in part, to protein instability. The patient with atypical symptoms had ∼20% of normal L-CPT I activity and was homozygous for a mutation (c.1436C→T) that substituted leucine for proline at codon 479. Assays performed with his cultured skin fibroblasts indicated that this mutation confers partial resistance to the inhibitory effects of malonyl-CoA. The demonstration of L-CPT I deficiency in this patient suggests that the spectrum of clinical sequelae associated with loss or alteration of L-CPT I function may be broader than was previously recognized.

Original languageEnglish (US)
Pages (from-to)1134-1142
Number of pages9
JournalJournal of Lipid Research
Volume42
Issue number7
StatePublished - 2001

Fingerprint

Carnitine O-Palmitoyltransferase
Carnitine
Enzymes
Mutation
Muscle
Carnitine palmitoyl transferase 1A deficiency
Malonyl Coenzyme A
Muscle Cramp
COS Cells
Myalgia
Mutant Proteins
Mitochondria
Hypoglycemia
Proline
Codon
Leucine
Enzyme activity
Transfection
Fibroblasts
Fasting

Keywords

  • Acylcarnitine
  • Fasting
  • Fatty acid oxidation
  • Hypoketotic hypoglycemia
  • Malonyl-CoA

ASJC Scopus subject areas

  • Endocrinology

Cite this

Brown, N. F., Mullur, R. S., Subramanian, I., Esser, V., Bennett, M. J., Saudubray, J. M., ... Cohen, J. C. (2001). Molecular characterization of L-CPT I deficiency in six patients: Insights into function of the native enzyme. Journal of Lipid Research, 42(7), 1134-1142.

Molecular characterization of L-CPT I deficiency in six patients : Insights into function of the native enzyme. / Brown, N. F.; Mullur, R. S.; Subramanian, I.; Esser, V.; Bennett, M. J.; Saudubray, J. M.; Feigenbaum, A. S.; Kobari, J. A.; Macleod, P. M.; McGarry, J. D.; Cohen, J. C.

In: Journal of Lipid Research, Vol. 42, No. 7, 2001, p. 1134-1142.

Research output: Contribution to journalArticle

Brown, NF, Mullur, RS, Subramanian, I, Esser, V, Bennett, MJ, Saudubray, JM, Feigenbaum, AS, Kobari, JA, Macleod, PM, McGarry, JD & Cohen, JC 2001, 'Molecular characterization of L-CPT I deficiency in six patients: Insights into function of the native enzyme', Journal of Lipid Research, vol. 42, no. 7, pp. 1134-1142.
Brown NF, Mullur RS, Subramanian I, Esser V, Bennett MJ, Saudubray JM et al. Molecular characterization of L-CPT I deficiency in six patients: Insights into function of the native enzyme. Journal of Lipid Research. 2001;42(7):1134-1142.
Brown, N. F. ; Mullur, R. S. ; Subramanian, I. ; Esser, V. ; Bennett, M. J. ; Saudubray, J. M. ; Feigenbaum, A. S. ; Kobari, J. A. ; Macleod, P. M. ; McGarry, J. D. ; Cohen, J. C. / Molecular characterization of L-CPT I deficiency in six patients : Insights into function of the native enzyme. In: Journal of Lipid Research. 2001 ; Vol. 42, No. 7. pp. 1134-1142.
@article{1ce2af5442804105b8b24cd811b08132,
title = "Molecular characterization of L-CPT I deficiency in six patients: Insights into function of the native enzyme",
abstract = "Carnitine palmitoyltransferase I (CPT I) catalyzes the formation of acylcarnitine, the first step in the oxidation of long-chain fatty acids in mitochondria. The enzyme exists as liver (L-CPT I) and muscle (M-CPT I) isoforms that are encoded by separate genes. Genetic deficiency of L-CPT I, which has been reported in 16 patients from 13 families, is characterized by episodes of hypoketotic hypoglycemia beginning in early childhood and is usually associated with fasting or illness. To date, only two mutations associated with L-CPT I deficiency have been reported. In the present study we have identified and characterized the mutations underlying L-CPT I deficiency in six patients: five with classic symptoms of L-CPT I deficiency and one with symptoms that have not previously been associated with this disorder (muscle cramps and pain). Transfection of the mutant L-CPT I cDNAs in COS cells resulted in L-CPT I mRNA levels that were comparable to those expressed from the wild-type construct. Western blotting revealed lower levels of each of the mutant proteins, indicating that the low enzyme activity associated with these mutations was due, at least in part, to protein instability. The patient with atypical symptoms had ∼20{\%} of normal L-CPT I activity and was homozygous for a mutation (c.1436C→T) that substituted leucine for proline at codon 479. Assays performed with his cultured skin fibroblasts indicated that this mutation confers partial resistance to the inhibitory effects of malonyl-CoA. The demonstration of L-CPT I deficiency in this patient suggests that the spectrum of clinical sequelae associated with loss or alteration of L-CPT I function may be broader than was previously recognized.",
keywords = "Acylcarnitine, Fasting, Fatty acid oxidation, Hypoketotic hypoglycemia, Malonyl-CoA",
author = "Brown, {N. F.} and Mullur, {R. S.} and I. Subramanian and V. Esser and Bennett, {M. J.} and Saudubray, {J. M.} and Feigenbaum, {A. S.} and Kobari, {J. A.} and Macleod, {P. M.} and McGarry, {J. D.} and Cohen, {J. C.}",
year = "2001",
language = "English (US)",
volume = "42",
pages = "1134--1142",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "7",

}

TY - JOUR

T1 - Molecular characterization of L-CPT I deficiency in six patients

T2 - Insights into function of the native enzyme

AU - Brown, N. F.

AU - Mullur, R. S.

AU - Subramanian, I.

AU - Esser, V.

AU - Bennett, M. J.

AU - Saudubray, J. M.

AU - Feigenbaum, A. S.

AU - Kobari, J. A.

AU - Macleod, P. M.

AU - McGarry, J. D.

AU - Cohen, J. C.

PY - 2001

Y1 - 2001

N2 - Carnitine palmitoyltransferase I (CPT I) catalyzes the formation of acylcarnitine, the first step in the oxidation of long-chain fatty acids in mitochondria. The enzyme exists as liver (L-CPT I) and muscle (M-CPT I) isoforms that are encoded by separate genes. Genetic deficiency of L-CPT I, which has been reported in 16 patients from 13 families, is characterized by episodes of hypoketotic hypoglycemia beginning in early childhood and is usually associated with fasting or illness. To date, only two mutations associated with L-CPT I deficiency have been reported. In the present study we have identified and characterized the mutations underlying L-CPT I deficiency in six patients: five with classic symptoms of L-CPT I deficiency and one with symptoms that have not previously been associated with this disorder (muscle cramps and pain). Transfection of the mutant L-CPT I cDNAs in COS cells resulted in L-CPT I mRNA levels that were comparable to those expressed from the wild-type construct. Western blotting revealed lower levels of each of the mutant proteins, indicating that the low enzyme activity associated with these mutations was due, at least in part, to protein instability. The patient with atypical symptoms had ∼20% of normal L-CPT I activity and was homozygous for a mutation (c.1436C→T) that substituted leucine for proline at codon 479. Assays performed with his cultured skin fibroblasts indicated that this mutation confers partial resistance to the inhibitory effects of malonyl-CoA. The demonstration of L-CPT I deficiency in this patient suggests that the spectrum of clinical sequelae associated with loss or alteration of L-CPT I function may be broader than was previously recognized.

AB - Carnitine palmitoyltransferase I (CPT I) catalyzes the formation of acylcarnitine, the first step in the oxidation of long-chain fatty acids in mitochondria. The enzyme exists as liver (L-CPT I) and muscle (M-CPT I) isoforms that are encoded by separate genes. Genetic deficiency of L-CPT I, which has been reported in 16 patients from 13 families, is characterized by episodes of hypoketotic hypoglycemia beginning in early childhood and is usually associated with fasting or illness. To date, only two mutations associated with L-CPT I deficiency have been reported. In the present study we have identified and characterized the mutations underlying L-CPT I deficiency in six patients: five with classic symptoms of L-CPT I deficiency and one with symptoms that have not previously been associated with this disorder (muscle cramps and pain). Transfection of the mutant L-CPT I cDNAs in COS cells resulted in L-CPT I mRNA levels that were comparable to those expressed from the wild-type construct. Western blotting revealed lower levels of each of the mutant proteins, indicating that the low enzyme activity associated with these mutations was due, at least in part, to protein instability. The patient with atypical symptoms had ∼20% of normal L-CPT I activity and was homozygous for a mutation (c.1436C→T) that substituted leucine for proline at codon 479. Assays performed with his cultured skin fibroblasts indicated that this mutation confers partial resistance to the inhibitory effects of malonyl-CoA. The demonstration of L-CPT I deficiency in this patient suggests that the spectrum of clinical sequelae associated with loss or alteration of L-CPT I function may be broader than was previously recognized.

KW - Acylcarnitine

KW - Fasting

KW - Fatty acid oxidation

KW - Hypoketotic hypoglycemia

KW - Malonyl-CoA

UR - http://www.scopus.com/inward/record.url?scp=0034947983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034947983&partnerID=8YFLogxK

M3 - Article

C2 - 11441142

AN - SCOPUS:0034947983

VL - 42

SP - 1134

EP - 1142

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 7

ER -